Search research articles
Contact Us
Filters
Showing results (61-70 of 1,253) with videos related to
Page
of 126
Sort By:
Diabetes Care
|
May 8, 1998
Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points
R M Califf, C B Granger
Journal of the American College of Cardiology
|
July 30, 2016
Stroke Prediction in Atrial Fibrillation: Is it Black and White?
Christopher B Granger, Kevin L Thomas
European Heart Journal
|
December 16, 2017
Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillation
Sean D Pokorney, Christopher B Granger
Circulation
|
April 14, 2020
Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus
Christopher B Granger, Kenneth W Mahaffey
Annals of Internal Medicine
|
September 16, 2015
Adding ezetimibe to simvastatin improved cardiovascular outcomes in stable acute coronary syndrome
Christopher B Fordyce, Christopher B Granger
European Heart Journal
|
May 23, 2018
Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?
Daniel J Friedman, Christopher B Granger
American Heart Journal
|
October 28, 1999
Diabetes and ischemic heart disease
D K McGuire, C B Granger
Lancet (London, England)
|
March 31, 2009
Advancing care for acute heart failure--no time to relax
Adrian F Hernandez, Christopher B Granger
Annals of Internal Medicine
|
April 21, 2010
Review: statins do not reduce mortality in patients with heart failure
Christopher B Granger, Chetan B Patel
Annals of Internal Medicine
|
August 17, 2011
ACP Journal Club. Meta-analysis: high-dose statin pretreatment prevents periprocedural cardiac events in patients having PCI
Emil L Fosbol, Christopher B Granger
Page
of 126
Search research articles
Search
Showing results (61-70 of 1,253) with videos related to
Sort By:
Page
of 126
Diabetes Care
|
May 8, 1998
Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points
R M Califf, C B Granger
Journal of the American College of Cardiology
|
July 30, 2016
Stroke Prediction in Atrial Fibrillation: Is it Black and White?
Christopher B Granger, Kevin L Thomas
European Heart Journal
|
December 16, 2017
Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillation
Sean D Pokorney, Christopher B Granger
Circulation
|
April 14, 2020
Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus
Christopher B Granger, Kenneth W Mahaffey
Annals of Internal Medicine
|
September 16, 2015
Adding ezetimibe to simvastatin improved cardiovascular outcomes in stable acute coronary syndrome
Christopher B Fordyce, Christopher B Granger
European Heart Journal
|
May 23, 2018
Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?
Daniel J Friedman, Christopher B Granger
American Heart Journal
|
October 28, 1999
Diabetes and ischemic heart disease
D K McGuire, C B Granger
Lancet (London, England)
|
March 31, 2009
Advancing care for acute heart failure--no time to relax
Adrian F Hernandez, Christopher B Granger
Annals of Internal Medicine
|
April 21, 2010
Review: statins do not reduce mortality in patients with heart failure
Christopher B Granger, Chetan B Patel
Annals of Internal Medicine
|
August 17, 2011
ACP Journal Club. Meta-analysis: high-dose statin pretreatment prevents periprocedural cardiac events in patients having PCI
Emil L Fosbol, Christopher B Granger
Page
of 126